Clinical Trial Update: MRD-guided Treatment in NPM1mut AML Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating MRD-guided treatment in patients with NPM1-mutated acute myeloid leukemia has been terminated, per the clinical trials update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Technische Universität Dresden | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED